Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Nordic Capital – aquisition of Finnveden AB
Mandate

Nordic Capital – aquisition of Finnveden AB

March 29, 2005

Nordic Capital, the Swedish private equity firm, has succesfully completed the public offer to acquire all outstanding shares of Finnveden AB, the Swedish engineering company, for a consideration of SEK 2.0bn (USD 288.1m), and currently holds more than 99% of the total number of shares and votes in Finnveden AB.

Vinge acted for Nordic Capital.
Johan Cederlund (responsible partner)
Sara Mindus (associate)

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026